{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:37:53Z","timestamp":1792017473271,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.alit.2024.08.006","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T19:39:59Z","timestamp":1726601999000},"page":"33-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Delayed drug hypersensitivity reactions: How p-i transforms pharmacology into immunology"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8117-359X","authenticated-orcid":false,"given":"Werner J.","family":"Pichler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2024.08.006_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000453265","article-title":"Classification of drug hypersensitivity into allergic, p-i, and pseudo-allergic forms","volume":"171","author":"Pichler","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ACI.0000000000000458","article-title":"Mechanisms leading to T-cell activation in drug hypersensitivity","volume":"18","author":"Meng","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/cod.12311","article-title":"New concepts in cutaneous allergy","volume":"72","author":"Martin","year":"2015","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.alit.2024.08.006_bib4","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.4049\/jimmunol.1700209","article-title":"Definition of the nature and hapten threshold of the \u03b2-lactam antigen required for T cell activation in\u00a0vitro and in patients","volume":"198","author":"Meng","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/all.14962","article-title":"The important role of non-covalent drug binding in drug hypersensitivity reactions","volume":"77","author":"Pichler","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/all.13765","article-title":"Immune pathomechanism and classification of drug hypersensitivity","volume":"74","author":"Pichler","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1016730","article-title":"Hypersensitivity reactions to small molecule drugs","volume":"13","author":"Han","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib8","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1111\/all.15795","article-title":"Drug hypersensitivity and eosinophilia: the decisive role of p-i stimulation","volume":"78","author":"Pichler","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(02)00222-0","article-title":"Superantigens: microbial agents that corrupt immunity","volume":"2","author":"Llewelyn","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.alit.2024.08.006_bib10","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nri2200","article-title":"Specificity of T-cell alloreactivity","volume":"7","author":"Felix","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40472-016-0115-8","article-title":"What is direct allorecognition?","volume":"3","author":"Boardman","year":"2016","journal-title":"Curr Transpl Rep"},{"key":"10.1016\/j.alit.2024.08.006_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/all.15558","article-title":"Viral infections and drug hypersensitivity","volume":"78","author":"Pichler","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.alit.2024.08.006_bib14","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2024.08.006_bib15","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B\u221713:01 and the dapsone hypersensitivity syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2024.08.006_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A\u221732:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib17","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.4049\/jimmunol.1302306","article-title":"Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B\u221758:01","volume":"192","author":"Yun","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076211","article-title":"Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRV\u03b220-1, altering peptHLA recognition","volume":"8","author":"Watkins","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2024.08.006_bib19","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib20","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1038\/s41467-019-11396-2","article-title":"Identification of drug-specific public TCR driving severe cutaneous adverse reactions","volume":"10","author":"Pan","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.alit.2024.08.006_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4236\/oji.2013.33019","article-title":"Activating interactions of sulfanilamides with T cell receptors","volume":"3\/3","author":"Watkins","year":"2013","journal-title":"Open J Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib22","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2024.08.006_bib23","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12145","article-title":"In\u00a0vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test","volume":"43","author":"Porebski","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jaci.2013.04.013","article-title":"HLA-B\u221757:01(+) abacavir-naive individuals have specific T cells but no patch test reactivity","volume":"132","author":"Schnyder","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"PREDICT-1 Study Team. HLA-B\u22175701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2024.08.006_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.alit.2024.08.006_bib27","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B\u22175801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.alit.2024.08.006_bib28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jaip.2024.02.041","article-title":"Association of HLA-A\u221711:01, HLA-B\u221739:01, and HLA-B\u221756:03 with salazosulfapyridine-induced cutaneous adverse drug reactions","volume":"12","author":"Fukunaga","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2024.08.006_bib29","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1172\/JCI99321","article-title":"A\u00a0transgenic mouse model for HLA-B\u221757:01-linked abacavir drug tolerance and reactivity","volume":"128","author":"Cardone","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.alit.2024.08.006_bib30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s42003-021-02657-2","article-title":"Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity","volume":"4","author":"Susukida","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.alit.2024.08.006_bib31","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.3390\/cells12212556","article-title":"Regulatory ILC2-role of IL-10 producing ILC2 in asthma","volume":"12","author":"Emami","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.alit.2024.08.006_bib32","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1067\/mai.2003.1507","article-title":"Characterization of drug-specific T cells in lamotrigine hypersensitivity","volume":"111","author":"Naisbitt","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib33","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.jid.2021.03.014","article-title":"HLA class-II\u2012restricted CD8+ T cells contribute to the promiscuous immune response in dapsone-hypersensitive patients","volume":"141","author":"Zhao","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2024.08.006_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","article-title":"MHC dependent presentation of the drug sulfamethoxazole to human T cell clones","volume":"100","author":"Schnyder","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.alit.2024.08.006_bib35","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI3544","article-title":"HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human ab T lymphocytes","volume":"102","author":"Zanni","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.alit.2024.08.006_bib36","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","article-title":"Recognition of sulfamethoxazole and its reactive metabolites by drug specific T cells from allergic individuals","volume":"164","author":"Schnyder","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/mol.105.021576","article-title":"Transfection of drug specific T cell receptors into hybridoma cells: tools to monitor drug binding to TCR and to evaluate cross-reactivity to related compounds","volume":"70","author":"Schmid","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.alit.2024.08.006_bib38","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.4049\/jimmunol.1202949","article-title":"HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin","volume":"190","author":"Wuillemin","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.804605","article-title":"The activation pattern of drug-reacting T cells has an impact on the clinical picture of hypersensitivity reactions","volume":"3","author":"Wuillemin","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib40","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1111\/1346-8138.17099","article-title":"Differential immune complex deposition in mild and severe drug-induced cutaneous reactions","volume":"51","author":"Hashizume","year":"2024","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2024.08.006_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15260","article-title":"An allosteric site in the T-cell receptor C\u03b2 domain plays a critical signalling role","volume":"8","author":"Natarajan","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.alit.2024.08.006_bib42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tibs.2017.11.008","article-title":"TCR signaling: mechanisms of initiation and propagation","volume":"43","author":"Courtney","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.alit.2024.08.006_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095339","article-title":"Abacavir induced T cell reactivity represents an allo-immune reaction","volume":"9","author":"Adam","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2024.08.006_bib44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/intimm\/13.7.877","article-title":"Degeneracy an additional alloreactivity of drug-specific human \u03b1\u03b2+ T cell clones","volume":"7","author":"Greyerz","year":"2001","journal-title":"Int Immun"},{"key":"10.1016\/j.alit.2024.08.006_bib45","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1046\/j.1365-2222.1998.00419.x","article-title":"T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction","volume":"28","author":"Schnyder","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1398-9995.2004.00460.x","article-title":"Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies","volume":"59","author":"Kuechler","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib47","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1365-2222.2000.00847.x","article-title":"Infiltration of cytotoxic T cells in drug induced cutaneous eruptions","volume":"30","author":"Yawalkar","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib49","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1073\/pnas.1913940117","article-title":"CD29 identifies IFN-\u03b3-producing human CD8+ T cells with an increased cytotoxic potential","volume":"117","author":"Nicolet","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2024.08.006_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe0013","article-title":"Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis","volume":"7","author":"Villani","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.alit.2024.08.006_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/eji.201142159","article-title":"Avidity determines T-cell reactivity in abacavir hypersensitivity","volume":"42","author":"Adam","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib52","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e328355fe8f","article-title":"Abacavir induces loading of novel self-peptides into HLA-B\u221757: 01: an autoimmune model for HLA-associated drug hypersensitivity","volume":"26","author":"Norcross","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.alit.2024.08.006_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier epithelial cells and the control of type 2 immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2024.08.006_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005374","article-title":"TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation","volume":"5","author":"Kim","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.alit.2024.08.006_bib55","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.10.016","article-title":"Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen","volume":"38","author":"Plantinga","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2024.08.006_bib56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00130832-200108000-00004","article-title":"Immunohistology of drug-induced exanthema: clues to pathogenesis","volume":"1","author":"Yawalkar","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib57","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1067\/mai.2000.110922","article-title":"Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions","volume":"106","author":"Yawalkar","year":"2000","journal-title":"J.Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib58","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jid.2023.09.282","article-title":"Differential effects of HLA-B\u221715:11 and HLA-A\u221731:01 on carbamazepine-induced cutaneous adverse reactions","volume":"144","author":"Fukunaga","year":"2024","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2024.08.006_bib59","article-title":"Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review","volume":"10","author":"Chen","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.alit.2024.08.006_bib60","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamadermatol.2021.5390","article-title":"Clinical characteristics, disease course, and outcomes of patients with acute generalized exanthematous pustulosis in the US","volume":"158","author":"Creadore","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2024.08.006_bib61","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/cup.14090","article-title":"Symmetric drug-related intertriginous and flexural exanthema: clinicopathologic study of 19 cases and review of literature","volume":"48","author":"Schuler","year":"2021","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.alit.2024.08.006_bib62","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI12118","article-title":"T-cell involvement in drug-induced acute generalized exanthematous pustulosis","volume":"107","author":"Britschgi","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.alit.2024.08.006_bib63","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jid.2018.10.023","article-title":"Culprit drugs induce specific IL-36 overexpression in acute generalized exanthematous pustulosis","volume":"139","author":"Meier-Schiesser","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2024.08.006_bib64","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann Int Med"},{"key":"10.1016\/j.alit.2024.08.006_bib65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1398-9995.2011.02720.x","article-title":"Multiple drug hypersensitivity: normal Treg cell function but enhanced in\u00a0vivo activation of drug-specific T cells","volume":"67","author":"Daubner","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2005.10.030","article-title":"Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions","volume":"117","author":"Beeler","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib67","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2024.08.006_bib68","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.mad.2006.01.011","article-title":"Human cytomegalovirus infection and T cell immunosenescence: a mini review","volume":"127","author":"Koch","year":"2006","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.alit.2024.08.006_bib69","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000458725","article-title":"Multiple drug hypersensitivity","volume":"172","author":"Pichler","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2024.08.006_bib70","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/all.14146","article-title":"The role of drug, dose, and the tolerance\/intolerance of new drugs in multiple drug hypersensitivity syndrome","volume":"75","author":"J\u00f6rg","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.827893","article-title":"Risk assessment in drug hypersensitivity: detecting small molecules which outsmart the immune system","volume":"3","author":"Pichler","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.alit.2024.08.006_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117160","article-title":"Abacavir-reactive memory T cells are present in drug na\u00efve individuals","volume":"10","author":"Lucas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2024.08.006_bib73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(83)91578-7","article-title":"Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride","volume":"1","author":"Black","year":"1983","journal-title":"Lancet."},{"key":"10.1016\/j.alit.2024.08.006_bib74","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Network of the French Pharmacovigilance Centers. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"155","author":"Peyri\u00e8re","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2024.08.006_bib75","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/tpj.2013.40","article-title":"HLA-A\u221731:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis","volume":"14","author":"Genin","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.alit.2024.08.006_bib76","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/all.14554","article-title":"Anaphylaxis to drugs: overcoming mast cell unresponsiveness by fake antigens","volume":"76","author":"Pichler","year":"2021","journal-title":"Allergy"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893024000881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893024000881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T23:57:45Z","timestamp":1736035065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893024000881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1323893024000881"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2024.08.006","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed drug hypersensitivity reactions: How p-i transforms pharmacology into immunology","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2024.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Allergology. Published by Elsevier B.V\u00e9","name":"copyright","label":"Copyright"}]}}